Evidence map›Paper›PMID 41357610›Full record

ArticleFrontiers in oncology2025

Range quality assurance measurements for clinical and FLASH proton beam therapy using the quality assurance range calorimeter.

Saad Shaikh, Sonia Escribano-Rodriguez, Raffaella Radogna, Ruben Saakyan, Sam Manger, Nicholas Henthorn, John-William Warmenhoven, Michael Taylor, Simon Jolly

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Saad ShaikhDepartment of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
Sonia Escribano-RodriguezDepartment of Physics and Astronomy, University College London, London, United Kingdom.
Raffaella RadognaDepartment of Physics, University of Bari, Bari, Italy.
Ruben SaakyanDepartment of Physics and Astronomy, University College London, London, United Kingdom.
Sam MangerDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Nicholas HenthornDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
John-William WarmenhovenDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Michael TaylorDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Simon JollyDepartment of Physics and Astronomy, University College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This work demonstrated the design and performance of a full-sized clinical prototype of the Quality Assurance Range Calorimeter (QuARC): a segmented large-volume scintillator-based detector for fast, accurate proton range quality assurance (QA) measurements. Materials & methods: The detector used 128 scintillator sheets of size 105 × 105 × 3 mm arranged into 4 modules of 32 sheets, where each sheet was directly coupled to a photodiode. Fast analogue-to-digital conversion facilitated measurement of scintillator sheet light output to 20-bit precision at 6 kHz, with a dynamic range of up to 350 pC. Results: Proton range measurements with the full-size detector were performed at the proton therapy research facility based at The Christie at clinical dose rates, corresponding to ∼1 nA nozzle current, where the range accuracy of the QuARC was found to be within 0.4 mm of facility reference across the full clinical energy range. The QuARC successfully performed range measurements of the 245 MeV beam at FLASH dose rate (∼50 nA nozzle current), where the fitted range agreed with the clinical current measurement to 0.3 mm. Preliminary results show charge linearity of the detector to be within 3%. Conclusions: The QuARC has been shown to be a promising candidate for fast, accurate range QA at conventional clinical dose rates and thanks to its high precision and dynamic range, has been shown to also be viable at FLASH dose rates. Future work will investigate improving the accuracy and stability of the calibration process by optimising the scintillator sheet light output and mechanical setup.

Indexed as

FLASHphotodiodeplastic scintillatorproton therapyrange quality assurance

Identifiers

PMID41357610
PMCPMC12678157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.